Cannabis ETFs: This Imminent Trigger Could Lead To A Definitive Repricing Of Assets

Wait 5 sec.

Skip to contentHome page Seeking Alpha - Power to InvestorsDec. 17, 2025 1:47 PM ETAdvisorShares Pure US Cannabis ETF (MSOS), WEED, MJ, CNBS, YOLOMultiplo Invest2.25K FollowersComments(2)SummaryI recommend buying cannabis sector ETFs. Recent news suggests imminent U.S. regulatory easing, potentially reclassifying marijuana and unlocking significant sector value.Current MJ ETF price/sales is 1.5x; I conservatively project a move to 2.5x, implying 66% upside.Key risks include regulatory uncertainty, sector profitability challenges, and historical underperformance post-IPOs.Morsa Images/DigitalVision via Getty ImagesInvestment ThesisI recommend buying assets that track the performance of the cannabis sector. I had intended to write about the topic for some time, but there was no trigger for the thesis. The fact is thatThis article was written byMultiplo Invest2.25K FollowersMore than 5 years of experience in equity analysis in LatAm. We provide our clients with in-depth research and insights to help them make informed investment decisions.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Comments(2)To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.